BCIQ Profiles

Company Profile ReportTarget Profile Report
1109 tau data
BioCentury & Getty Images

Product Development

First biomarker data from pioneering tau program in Alzheimer’s cloud use of antibodies for the target 

Genentech, AC Immune look ahead to data in moderate Alzheimer’s for semorinemab

Nov 10, 2020 | 2:54 AM GMT

Data presented at the annual CTAD meeting hint that anti-tau therapy semorinemab from Genentech and AC Immune may have engaged

Read the full 591 word article

How to gain access

Continue reading with a
two-week free trial.